ClinicalTrials.Veeva

Menu

Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation

U

Universitaire Ziekenhuizen KU Leuven

Status

Completed

Conditions

Breast Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01684735
B322201213618

Details and patient eligibility

About

Evaluation of the response to chemotherapy in breast cancer patients by the use of Diffusion-weighted magnetic resonance imaging of the breast before the start of chemotherapy, after one and 3 cycles of therapy and at the end of the therapy.

Enrollment

45 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • core biopsy with diagnosis of breast cancer
  • start of neo-adjuvant chemotherapy

Exclusion criteria

  • magnetic resonance imaging incompatibility

Trial design

45 participants in 1 patient group

women with BRCA and chemotherapy
Description:
women recently diagnosed with breast cancer and start with neo-adjuvant chemotherapy (6 cycles) before surgery/therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems